Journal Profile | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journal Title | BIOMEDICINE & PHARMACOTHERAPY | ||||||||||||||||
Journal Title Abbreviations | BIOMED PHARMACOTHER | ||||||||||||||||
ISSN | 0753-3322 | ||||||||||||||||
h-index | 78 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
Self-Citation Ratio (2019-2020) | 4.50% | ||||||||||||||||
Official Website | http://www.journals.elsevier.com/biomedicine-and-pharmacotherapy/ | ||||||||||||||||
Online Manuscript Submission | https://www.editorialmanager.com/BIOPHA | ||||||||||||||||
Open Access | No | ||||||||||||||||
Publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724 | ||||||||||||||||
Subject Area | Medicine | ||||||||||||||||
Country/Area of Publication | FRANCE | ||||||||||||||||
Publication Frequency | Monthly | ||||||||||||||||
Year Publication Started | 1982 | ||||||||||||||||
Annual Article Volume | 1403 | ||||||||||||||||
Indexing (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0753-3322%5BISSN%5D | ||||||||||||||||
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Average 2 Month(s) Data from Elsevier: Average 7 Week(s) | ||||||||||||||||
Competitiveness * | Data from Authors: About 50% | ||||||||||||||||
Online Article Publication Time | Data from Elsevier: Average 3 Week(s) | ||||||||||||||||
Useful Links |
| ||||||||||||||||
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |
|
|
|
First Previous 1 Next Last (To Page | |
Reviews on BIOMEDICINE & PHARMACOTHERAPY: | Write a review |
Author: 顺子 Subject Area: Medicine Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2019-04-02 14:48:50 This journal is about to become the next Medicine or PLoS One. In 2016, 725 articles were published throughout the year, and it expanded to 1625 in 2017, and 1844 in 2018. Besides, since the end of last year it began to charge US$2800 per page, the impact factor will definitely fall and it might get a bad reputation. But the IF coming out this year may still be close to 4. I just wrote a review paper of less than 7 pages in February, and it was returned within one month, and got accepted soon after revisions. It is estimated that the number of articles published this year exceeds 2000, and about 50% of the articles are from the mainland China major in medicine. ![]() ![]() |
Author: Matthew麦麸 Subject Area: Medicine Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2018-09-20 13:36:05 I have only positive comments about Biomedicine & Pharmacotherapy. The review speed is fast; one typically receives reviews in less than one month. Furthermore, there are no page layout fees, and the editor is professional, timely and helpful throughout the review process. ![]() ![]() |
Author: fengfenghaha Subject Area: Medicine Duration of Peer Review: 1.0 month(s) Result: Accepted after revision Write a review |
Reviewed 2019-02-22 00:53:29 Relatively good submitment, one month overhaul, make up the experiment, after repairingReceived in one week. ![]() ![]() |
Author: 313263788@qq.com Subject Area: Medical Science Duration of Peer Review: 3.0 month(s) Result: Accepted directly Write a review |
Reviewed 2017-11-24 12:18:30 This journal is very fast and has a high quality.It takes 3 months from submission to reception.However, the preliminary work should be serious, and the content of the article should be considered. It is best to polish it.The content should be novel, and articles related to clinical medication are easy to accept. ![]() ![]() |
First Previous 1 Next Last (To Page |